Journal of Neurochemistry · 2002 · 70 citations · 54 references
MedicineNeurobiologyNeuroscienceCellular NeuroscienceNeuropharmacologyNeuroplasticityAntidepressant TherapyNeural DifferentiationNeurite OutgrowthNeuronal DifferentiationNeuronal Gene ExpressionNeurotransmissionAbnormal Neural PlasticityMajor DepressionMechanisms Of Antidepressant ActionNeurobiology Of DepressionNeuronal Cell MorphologyNoradrenergic ModulationNoradrenergic NeurotransmissionNorepinephrine Signaling
Recent research into depression has focused on the involvement of long-term intracellular processes, leading to abnormal neuronal plasticity in brains of depressed patients, and reversed by antidepressant treatment. Given a suggested decrease in noradrenergic transmission in depression, and an antidepressant induced increase in norepinephrine (NE) level, a possible role for NE in mediating alterations in neuronal morphology and plasticity was examined. Human neuroblastoma SH-SY5Y cells treated with 10-5 m NE presented an elongated granule-rich cell-body and increased number of neurites, when compared with non-treated cells. Moreover, cell survival was enhanced in the presence of NE, while proliferation was inhibited. The above effects suggest a role for NE in cell differentiation. Indeed similar effects on cell survival and neurite outgrowth were induced in SH-SY5Y cells by retinoic acid (RA), an established differentiating agent. Finally, NE treatment resulted in a progressive decrease in the pluripotent marker Oct4 and an increase in the neuronal growth cone marker, growth-associated-protein 43 (GAP-43). Alongside these effects, NE-treated cells presented alterations in the expression of 44 genes as observed in a neurobiology cDNA microarray. Among the altered genes, an increase in the expression level of two neurite-outgrowth promoting genes, neural cell adhesion molecule L1 and laminin, was confirmed by RT-PCR. Taken together, the results support a role for NE in processes of synaptic connectivity, and may point to a role for this neurotransmitter in mediating the suggested neuronal plasticity in depression and in antidepressant treatment.
54
Subgenual prefrontal cortex abnormalities in mood disorders
Wayne C. Drevets, Joseph L. Price, Joseph R. Simpson et al. · Nature · 1997 · 2.7K citations
Medicine, Neuroscience, Psychiatry +14
Hippocampal atrophy in recurrent major depression.
Yvette I. Sheline, P W Wang, M. Gado et al. · Proceedings of the National Academy of Sciences · 1996 · 1.9K citations
Hippocampal Volume Reduction in Major Depression
J. Douglas Bremner, Meena Narayan, Eric Anderson et al. · American Journal of Psychiatry · 2000 · 1.7K citations
Medicine, Neuroscience, Psychiatry +14